Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
ACS Nano · 2024
DOI: 10.1021/acsnano.4c05544 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Byeongmin Park und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea. Hauptthemen laut MEDLINE: Mesalamine, Prodrugs, Macrophages, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Institute of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Kyung Hee University, Seoul 02453, Republic of Korea.
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.
- Department of Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
- Division of Bio-Medical Science and Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
ORCID-Profile: Sangmin Lee, Kwangmeyung Kim, Yoosoo Yang, Yongju Kim, Jun-Seob Kim, Man Kyu Shim
Förderung
- National Research Foundation of Korea
- Korea Institute of Science and Technology
Zitieren
APA
Park, B., Han, G., Jin, D. Y., Gil, K. C., Shin, D., Lee, J., Park, J. Y., Jang, H., Park, D., Lee, S., Kim, K., Yang, Y., Kim, Y., Kim, J. S., Kim, S. H., & Shim, M. K. (2024). Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease. ACS Nano. https://doi.org/10.1021/acsnano.4c05544
Vancouver
Park B, Han G, Jin DY, Gil KC, Shin D, Lee J, et al. Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease. ACS Nano. 2024. doi:10.1021/acsnano.4c05544
BibTeX
@article{Park2024,
author = {Park, Byeongmin and Han, Geonhee and Jin, Do Young and Gil, Ki Cheol and Shin, Dongwon and Lee, Jongwon and Park, Jung Yeon and Jang, Hochung and Park, Daeho and Lee, Sangmin and Kim, Kwangmeyung and Yang, Yoosoo and Kim, Yongju and Kim, Jun-Seob and Kim, Sun Hwa and Shim, Man Kyu},
title = {Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c05544}
}
EUVIMED